leadf
logo-loader
viewTHC Global Group Ltd

THC Global gets strong support from directors for share purchase plan

The share purchase plan followed the completion of an institutional placement in late June 2020, taking the total amount raised by the company in this capital raising to $8.136 million at 30 cents per share.

THC Global Group Ltd - THC Global gets strong support from directors for share purchase plan
Over the past few months, THC has achieved a number of significant milestones

THC Global Group Ltd (ASX:THC) (OTCMKTS:HDRPF) (FRA:9TH) directors have demonstrated their confidence in the company’s medicinal cannabis strategy via their participation in the company’s share purchase plan.

Chairman Steven Xu and non-executive director Lou Cattelan acquired 83,334 shares each at a price of 30 cents per share.

SPP completed

Earlier this month, the company completed its share purchase plan, raising $1.535 million from 312 eligible shareholders.

The SPP followed the completion of an institutional placement in late June 2020, taking the total amount raised by the company in this capital raising to $8.136 million at 30 cents per share.

Production volumes increase

Funds raised will be primarily applied towards working capital for the company as production volumes rapidly increase at its Southport Facility.

Additionally, part of the funds will be applied towards expanding the company’s finished goods capabilities into additional medicine forms and to develop new IT infrastructure to support doctors and pharmacies supplying medicinal cannabis medicines for both Canndeo and Tetra Health.

Chief executive officer Ken Charteris recently said: “We’re pleased to have now completed this capital raising, securing over $8.1 million for the company.”

“Over the past few months, we have achieved a number of significant milestones as a company including supplying our Canndeo medicine to our first Australian patients, signing production agreements which will see THC Global manufacturing medicines for multiple brands, securing export agreements into New Zealand and soon Canada, and achieving continued patient and revenue growth across the business.

“We look forward to building on these successes now with a stronger balance sheet to take us forward.”

Quick facts: THC Global Group Ltd

Price: 0.255 AUD

ASX:THC
Market: ASX
Market Cap: $44.87 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of THC Global Group Ltd named herein, including the promotion by the Company of THC Global Group Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Full interview: THC Global Group granted GMP Licence for Southport cannabis...

THC Global Group Limited (ASX:THC) chief executive officer Ken Charteris updates Proactive on being granted a licence to manufacture therapeutic goods for the company’s Southport Facility, known as a GMP Licence, by the Australian Therapeutic Goods Administration (TGA). This milestone...

on 29/1/20

2 min read